Apoptosis induction by Epican Forte in HTLV-1 positive and negative malignant T-cells

Leukemia Research

Volumn 30, Issue 7, 2006, Pages 869-881

  Harakeh, S ^a   Diab Assaf, M ^a   Niedzwiecki, A ^b   Khalife, J ^a   Abu El Ardat, K ^a   Rath, M ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Dr Rath Research Institute   (United States)

Author keywords

Amino acids; Antioxidants; Apoptosis; Ascorbic acid (AA); Epican Forte; Epigallocatechin 3 gallate (EGCG); HTLV 1; Leukemia

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; EPICAN FORTE; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UPREGULATION;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARGININE; ASCORBIC ACID; CATECHIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COPPER; DIETARY SUPPLEMENTS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LYSINE; MANGANESE; PROLINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELENIUM; SENSITIVITY AND SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTORS;

EID: 33744526743     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.11.027     Document Type: Article

References (67)

1. Rath M., and Pauling L. Plasmin-induced proteolysis and the role of apoprotein-a, lysine and synthetic lysine analogs. J Orthomol Med 7 (1991) 17-23
2. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vivo antitumor effect of ascorbic acid, lusine, praline and green tea extract on human colon cancer cell HTC 116 xenographs in nude mice. Oncol Rep 12 (2005) 421-425
3. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Antitumor effect of nutrient synergy on human osteosarcoma cells U2OS, MMNG-HOS, and Ewing's sarcoma SK-ES.1. Oncol Rep 13 (2005) 253-257
4. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vivo antitumor effect of ascorbic acid, lysine, praline, and green tea extract on human prostate cancer PC-3 xenographs in nude mice: evaluation of tumor growth and immunohistochemistry. In Vivo 19 (2005) 179-184
5. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Modulation of N-methyl-N-nitrosourea induced mammary tumors in Spargue-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res 7 (2005) R291-R295
6. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Synergistic effect of combination of lysine, proline, arginine, ascorbic acid and epigallocathechin gallate on colon cancer cell line HT116. J Am Nutrac Assoc 7 (2004) 40-43
7. Harakeh S., Jariwalla R.J., and Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci USA 87 (1990) 7245-7249
8. Harakeh S., and Jariwalla R.J. Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells. Am J Clin Nutr 54 (1991) 1231-1235
9. Harakeh S., Niedzwiecki A., and Jariwalla R.J. Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus. Chemico-Biol Interact 91 (1994) 207-215
10. Harakeh S., and Jariwalla R.J. Comparative analysis of ascorbate and AZT effects on HIV production in persistently infected cell lines. J Nutr Med 4 (1994) 393-401
11. Harakeh S., and Jariwalla R.J. Ascorbate effect on cytokine stimulation of HIV production. Nutrition 11 (1995) 684-687
12. Harakeh S., and Jariwalla R.J. Effect of ascorbic acid and N-acetyl-l-cysteine on NF-κB in cells stimulated by PMA and TNF-α. AIDS Res Human Retroviruses 13 (1997) 235-239
13. Maramag C., Menon M., Balaji K.C., Reddy P.G., and Laxmanan S. Effect of Vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate 32 (1997) 188-195
14. Roomi M.W., Niedzwiecki A., and Rath M. Cancer: an overview and cellular medecine breakthrough (2003), Mathias Rath Publishing
15. Hare Y. Green tea: health benefits and applications (2001), Marcel Dekker, New York, Basel
16. Hayakawa S., Saeki K., Sazuka M., Suzuki Y., Shoji Y., Ohta T., et al. Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun 285 (2001) 1102-1106
17. Ahmad N., Gupta S., and Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells. Arch Biochem Biophys 376 (2000) 338-346
18. Li H., Yashiki S., Sonoda J., Lou H., Ghosh S.K., Byrnes J.J., et al. Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients. Jpn J Cancer Res 91 (2000) 34-40
19. Roy M., Chakrabarty S., Sinha D., Bhattacharya R., and Siddiqi M. Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol. Mut Res 524 (2003) 33-41
20. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, acorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7. Med Oncol 22 (2005) 129-138
21. Tosetti F., Ferrari N., De Flora S., and Albini A. Angioprevention: angiogenesis is a common and key target for cancer chemo-preventive agents. FASEB J 16 (2002) 12-14
22. Agarwal A., Munoz-Najar U., Klueh U., Shih S.C., and Claffey K.P. N-Acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer. Am J Pathol 164 (2004) 1683-1696
23. Rath M., and Pauling L. Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic lysine analogs. J Ortho Med 7 (1992) 17-23
24. Sun Z., Chen Y.H., Wang P., Zhang J., Gurewich V., Zhang P., et al. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Biochim Biophys Acta 1596 (2002) 182-192
25. Yoon S.O., Kim M.M., and Chung A.S. Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem 276 (2001) 20085-20092
26. Morini M., Cai T., Aluigi M.G., Noonan D.M., Masiello L., De Flora S., et al. The role on N-acetyl cysteine in the prevention of tumor invasion and angiogenesis. Int J Bio Markers 14 (1999) 268-271
27. Fleming J., Ghose A., and Harrison P.R. Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer 40 (2001) 42-49
28. Cooke J.P., and Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48 (1997) 489-509
29. Simeone A.M., Ekmekcioglu S., Broemeling L.D., Grimm E.A., and Tari A.M. A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide. Mol Cancer Ther 1 (2002) 1009-1017 Erratum in: Mol Cancer Ther 2002;1:1366
30. Kawakami K., Kawakami M., and Puri R.K. Nitric oxide accelerates interleukin-13 cytotoxin-mediated regression in head and neck cancer animal model. Clin Cancer Res 10 (2004) 5264-5270
31. Chubinskaia S.G., Sevast'ianova N.A., Veksler I.G., and Slutskii L.I. Biochemical changes in the connective tissue components of malignant tumors and lungs in mice during metastatic spreading and chemotherapy. Vopr Med Khim 35 (1989) 30-34
32. Okazaki I., Matsuyama S., Suzuki F., Maruyama K., Maruta A., Kubochi K., et al. Endogenous urinary 3-hydroxyproline has 96% specificity and 44% sensitivity for cancer screening. J Lab Clin Med 120 (1992) 908-920
33. Ostrakhovitch E.A., and Cherian M.G. Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc. Arch Biochem Biophys 423 (2004) 351-361
34. Kinscherf R., Claus R., Wagner M., Gehrke C., Kamencic H., Hou D., et al. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent. FASEB J 12 (1998) 461-467
35. Slattery M.L., Edwards S.L., Boucher K.M., Anderson K., and Caan B.J. Lifestyle and colon cancer: an assessment of factors associated with risk. Am J Epidemiol 150 (1999) 869-877
36. Kampman E., Slattery M.L., Caan B., and Potter J.D. Calcium, Vitamin D, sunshine exposure, dairy products and colon cancer risk. Cancer Causes Contr 11 (2000) 459-466
37. Holt P.R., Atillasoy E.O., Gilman J., Guss J., Moss S.F., Newmark H., et al. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 280 (1998) 1074-1079
38. Baron J.A., Beach M., Mandel J.S., van Stolk R.U., Haile R.W., Sandler R.S., et al., Calcium Polyp Prevention Study Group. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 340 (1999) 101-107
39. Wu K., Willett W.C., Fuchs C.S., Colditz G.A., and Giovannucci E.L. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94 (2002) 437-446
40. Cascinu S., Ligi M., Del Ferro E., Foglietti G., and Cioccolini P. Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer. Cancer Invest 18 (2000) 411-416
41. Martinez M.E., and Willett W.C. Calcium, Vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7 (1998) 163-168
42. Foley G.E., Lazarius H., Farber S., Uzman B.G., Boone B.A., and McCarthy R.E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 10 (1965) 522-529
43. Guchelaar H.J., Vermes I., Koopmans R.P., Reutelingsperger C.P., and Haanen C. Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol 42 (1998) 77-83
44. Harakeh S., Diab-Assaf M., El-Sabban M., and Gali-Muhtasib H. Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6, 7-dichloroquinoxaline 1, 4-dioxide in adult T-cell leukemia cells. Chemico-Biol Interact 148 (2004) 101-113
45. Kanai M., Konda Y., Nakajima T., Izumi Y., Takeuchi T., and Chiba T. TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappaB-dependent pathway. Gastroenterology 121 (2001) 56-67
46. Mori N., Yamada Y., Ikeda S., Yamasaki Y., Tsukasaki K., Tanaka Y., et al. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100 (2002) 1828-1834
47. Dunker K.N., Schmitt K., Schuster K., and Krieglstein K. The role of transforming growth factor beta-2, beta-3 in mediating apoptosis in the murine intestinal mucosa. Gastroenterology 122 (2002) 1364-1375
48. Wahl S.M. Transforming growth factor beta (TGF-beta) in inflammation: a cause and cure. J Clin Immunol 12 (1992) 61-74
49. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon, Derynck R.M., et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T-cell growth. J Exp Med 163 (1986) 1037-1050
50. Mortenson M.M., Schlieman M.G., Virudalchalam S., and Bold R.J. Overexpression of BCL-2 results in activation of the AKT/NF-kB Cell survival pathway. J Surg Res 114 (1986) 302
51. Van Orden K., Giebler H.A., Lemasson L., Gonzales L., and Nyborg J.K. Binding of p53 to the KIX domain of CREB binding protein. J Biol Chem 274 (1999) 26321-26328
52. Ashcroft M., Kubbutat M.H.G., and Vousden K.H. Regulation of p53 function and stability by phosphorylation. Mol Cell Biol 19 (1999) 1751-1758
53. Bunz F., Hwang P.M., Torrance C., Waldman T., Zhang Y., Dillehay L., et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104 (1999) 263-269
54. Chen J.J., Ye Z.Q., and Koo M.W. Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line. BJU Int 93 (2004) 1082-1086
55. Ahn W.S., Huh S.W., Bae S.M., Lee I.P., Lee J.M., Namkoong S.E., et al. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA Cell Biol 22 (2003) 217-224
56. Gupta S., Hussain T., and Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410 (2003) 177-185
57. Kuo P.L., and Lin C.C. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci 10 (2003) 219-227
58. Jamison J.M., Gilloteaux J., Nassiri M.R., Venugopal M., Neal D.R., and Summers J.L. Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following Vitamin C and Vitamin K3 treatment. Biochem Pharmacol 67 (2004) 337-351
59. Reddy V.G., Khanna N., and Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem Biophys Res Commun 282 (2001) 409-415
60. Ip C., and Dong Y. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer Res 21 (2001) 863-867
61. Gopee N.V., Johnson V.J., and Sharma R.P. Sodium selenite-induced apoptosis in murine B-lymphoma cells is associated with inhibition of protein kinase C-{delta}, nuclear factor {kappa}B, and inhibitor of apoptosis protein. Toxicol Sci 78 (2004) 204-214
62. Zhong W., and Oberley T.D. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 61 (2001) 7071-7078
63. Swede H., Dong Y., Reid M., Marshall J., and Ip C. Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture. Cancer Epidemiol Biomarkers Prev 12 (2003) 1248-1252
64. Dong Y., Zhang H., Hawthorn L., Ganther H.E., and Ip C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res 63 (2003) 52-59
65. Gansauce S., Nussler A.K., Beger H.G., and Gansauge F. Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Growth Differ 9 (1998) 611-617
66. Wolf F.I., and Cittadini A. Magnesium in cell proliferation and differentiation. Front Biosci 47 (1999) D607-D617
67. Liu M.J., Wang Z., Ju Y., Wong R.N., and Wu Q.Y. Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis. Cancer Chemother Pharmacol 55 (2005) 79-90